![Robert J. Stagg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert J. Stagg
Plus aucun poste en cours
Profil
Robert J.
Stagg worked as a Medical Monitor at Genentech, Inc. from 1991 to 1993.
He then worked as the Director of Clinical Research at Gilead Sciences, Inc. from 1993 to 1996.
From 1996 to 2001, he worked as the Vice President of Clinical Research at Coulter Pharmaceuticals, Inc. He then worked as the Senior Director of Clinical Research at Tularik, Inc. from 2001 to 2003.
From 2003 to 2006, he worked as the Vice President of Regulatory Affairs & Safety at Protein Design Labs, Inc. He also worked as an Assistant Clinical Professor at The University of California, San Francisco from 1983 to 1991.
He was the Senior VP of Clinical Research and Development at OncoMed Pharmaceuticals, Inc. from 2016 to 2019.
He holds a doctorate degree from the University of the Pacific.
Anciens postes connus de Robert J. Stagg
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | - |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Conseiller Juridique Général | 10/01/2006 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Directeur Technique/Scientifique/R&D | 01/05/2003 |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Directeur Technique/Scientifique/R&D | 01/01/2001 |
| GILEAD SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/12/1996 |
Formation de Robert J. Stagg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
